Connect your AI

Veracyte VCYT Prepaid & Other Current

Prepaid & Other Current at other companies

Guardant HealthGH

$43.49M+21.6%

Natera, Inc.NTRA

$75.57M+34.5%

Bio-Rad LaboratoriesBIO

$150M+19.6%

RevvityRVTY

$189.11M+4.1%

Labcorp HoldingsLH

$629.5M-4.3%

Quest DiagnosticsDGX

$361M+22.8%

Other financials

Income statement

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

Market cap$4.29B+10.7%

Profitability

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Veracyte's prepaid & other current?: Veracyte (VCYT) reported prepaid & other current of $11.59M in Q1 2026.
How has Veracyte's prepaid & other current changed year-over-year?: Veracyte's prepaid & other current decreased by 34.8% year-over-year, from $17.76M to $11.59M.
What is the long-term trend for Veracyte's prepaid & other current?: Over 5 years (2020 to 2025), Veracyte's prepaid & other current has grown at a 26.3% compound annual growth rate (CAGR), from $3.2M to $10.28M.
What does prepaid & other current mean?: Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.